MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
AFIB - Acutus Medical Inc
$25.63
-0.32(-1.25%)7:47:17 PM 1/25/2021
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. It offers AcQMap console and workstation, an advanced imaging, navigation, and mapping system for physicians to map, treat, re-map, and adjust additional therapy as needed; and Patient Electrode Kit that is required in every procedure to provide cardiac signals, catheter localization, and AcQMap system grounding. The company also provides diagnostic and monitoring devices, such as AcQMap 3D Imaging and Mapping Catheter that is used for mapping during the electrophysiology procedures; conventional diagnostic catheters, including multi-polar, steerable, and loop catheters that are used during the mapping and ablation procedures; and reprocessed diagnostic catheters, such as diagnostic, multipole, fixed, steerable, and advanced mapping and imaging catheters. In addition, the company provides access devices, which include AcQRef Introducer that provides stable electrical reference and vascular access; AcQGuide MAX Steerable Introducer, which provides a stable platform for catheter passage and precision placement; and Transseptal Access Products. Further, it offers therapeutic devices, such as AcQBlate FORCE Ablation Catheters, AlCath Ablation Catheters, MedFact Robotic Navigation Enabled Ablation Catheters, Qubic Force, Qubic RF Generator and Pulse Stimulator, and Qiona Pump. The company also provides various software mapping modes comprises single position, supermap, contact mapping, and stereotaxis integration. Acutus Medical, Inc. was founded in 2011 and is based in Carlsbad, California.
Stock Chart

Summary:

  • A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
Peers

Related Peers

Stock news

    01/13/2021AFIB
    Acutus Medical Reports Preliminary, Unaudited Fourth Quarter and Full Year 2020 Results

    CARLSBAD, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020. Preliminary Fourth Quarter and Full Year Results: * Preliminary unaudited revenue is expected to be in the range of $2.4 million to $2.6 million for the fourth quarter of 2020, a 25...

    12/28/2020AFIB
    Acutus Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference

    CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that its management will present at the upcoming J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021 at 10:00 a.m. Eastern Time. A live, audio-only webcast of the presentation may be accessed by visiting ir.acutusmedical.com. A replay of the webcast...

    12/17/2020AFIB
    Is AFIB A Good Stock To Buy Now?

    In this article we will check out the progression of hedge fund sentiment towards Acutus Medical, Inc. (NASDAQ:AFIB) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and […]

    12/10/2020AFIB
    Acutus Medical Announces CE Mark and European Launch of AcQCross™ Transseptal System, a Fully Integrated Family of Transseptal Crossing Products

    Designed to Improve Safety and Efficiency in Any Procedure Requiring Left Heart AccessCARLSBAD, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced CE Mark and European launch of their integrated family of transseptal crossing products, designed to deliver safe and efficient access to the left atrium. Coupled with their previously received FDA clearanc...

    12/7/2020AFIB
    Acutus Medical Launches AcQBlate® Force Sensing Ablation System in Europe

    Gold-Tipped Force Sensing Ablation Catheter Earns CE Mark, Expanding Acutus’ Comprehensive Electrophysiology Portfolio AcQBlate FORCE Sensing Ablation System A complete ablation system with the smallest footprint in the electrophysiology industry, which includes the Qubic Force Module, Qubic RF Generator, Qiona Irrigation pump and controller. AcQBlate FORCE Sensing Ablation Catheter AcQBlate FORCE: the first and only force sensing ablation catheter with a gold tip electrode.CARLSBAD, Calif., Dec...

    12/3/2020AFIB
    Is Acutus Medical (AFIB) a Smart Long-term Buy?

    Baron Discovery Fund recently published its third-quarter commentary – a copy of which can be downloaded here. During the third quarter of 2020, the Baron Discovery Fund returned 18.83% (institutional shares). This was 11.67% better than the Russell 2000 Growth Index, the Fund’s primary benchmark index. You should check out Baron Discovery Fund’s top 5 […]

    11/12/2020AFIB
    Steven Mickelsen, MD, Joins Acutus Medical as Chief Translational Science Officer

    CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB) today announced the appointment of Steven Mickelsen, MD, as Chief Translational Science Officer. Dr. Mickelsen will help guide the company’s vision to deliver the most advanced electrophysiology therapeutic solutions on the market for physicians and their patients. Mickelsen’s impact will further advance the company’s commitment to innovation across its access, diagnostic and therapy product portfolio, including re...

    11/12/2020AFIB
    Acutus Medical Reports Third Quarter 2020 Results

    CARLSBAD, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the third quarter of 2020. Recent Highlights: * Reported revenue of $3.2 million in the third quarter ended September 30, 2020, a 180% increase sequentially and a 391% increase over the same quarter last year. * Increased worldwide installed base of second gene...

    11/12/2020AFIB
    Acutus Medical Inc to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Acutus Medical Inc (NASDAQ:AFIB) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 12, 2020 at 5:00 PM Eastern Time.